宣肃止咳汤联合吸入型糖皮质激素治疗小儿支气管肺炎疗效及对血清VCAM-1、Th1/Th2细胞因子的影响

摘要/Abstract

摘要： 目的探讨宣肃止咳汤联合吸入型糖皮质激素治疗小儿支气管肺炎的疗效及对血清血管细胞间黏附分子-1（VCAM-1）、Th1/Th2细胞因子的影响。方法选择2021年5月—2023年5月府谷县中医医院收治的80例支气管肺炎患儿作为研究对象,依据随机数表法将其分为对照组与试验组,各40例。对照组予以吸入型糖皮质激素治疗,试验组予以吸入型糖皮质激素联合宣肃止咳汤治疗。记录两组患儿临床症状消失时间,评价临床疗效,并检测治疗前后血清血管细胞间黏附分子-1（VCAM-1）、干扰素（IFN）-γ、白介素（IL-4）水平。结果与对照组比较,试验组咳嗽、喘鸣音、气促消失时间明显缩短,差异有统计学意义（P<0.05）;两组发热消失时间比较,差异无统计学意义（P>0.05）;试验组的总有效率高于对照组,差异有统计学意义（P<0.05）;与治疗前相比,两组治疗后血清VCAM-1、IFN-γ、IL-4及IFN-γ/IL-4比值均明显改善,且试验组治疗后血清IFN-γ、IL-4及IFN-γ/IL-4比值改善明显优于对照组,差异有统计学意义（P<0.05）;两组血清VCAM-1比较,差异无统计学意义（P>0.05）;两组患儿均未见明显不良反应。结论宣肃止咳汤联合吸入型糖皮质激素治疗小儿支气管肺炎可有效促进症状改善,提高临床疗效,并能调节Th1/Th2细胞失衡。

关键词: 支气管肺炎, 宣肃止咳汤, 糖皮质激素, 血管细胞间黏附分子-1, Th1/Th2细胞

Abstract: Objective To investigate the therapeutic effect of Xuansu Zhike Decoction combined with inhaled glucocorticoid in the treatment of bronchial pneumonia in children and the influence of serum vascular intercellular adhesion molecule 1 (VCAM-1) and Th1/Th2 cytokines. Methods From May 2021 to May 2023,80 children of bronchopneumonia were selected. The random number table method was divided into two groups, 40 cases each. The control group was treated with glucocorticoids, and the test group was treated with glucocorticoids combined with Xuanwu cough soup. The time to disappearance of clinical symptoms was recorded in both groups of children, the clinical efficacy was evaluated, and the serum intercellular adhesion molecule-1 (VCAM-1), interferon (IFN) - γ, and interleukin (IL-4) levels were detected before and after treatment. Results Compared with the control group, The duration of cough, wheezing and shortness of breath decreased significantly (P<0.05), However, the fever disappearance time of the two groups was not significant difference(P>0.05); The overall response rate of the patients in the test group was 95.00%, The overall response rate of the control patients was 77.50%, The total response rate of patients in the test group was significantly higher than that in the control group (P<0.05); Compared with the control group, the serum IFN- γ, IL-4 and IFN- γ / IL-4 ratios improved significantly better than those of the control group (P<0.05), and the serum VCAM-1 was not significant difference(P>0.05); no significant adverse effects were seen in either group. Conclusion Xuansu cough relieving decoction combined with glucocorticoid in the treatment of pediatric bronchopneumonia can effectively promote the improvement of symptoms, improve clinical efficacy, and regulate the imbalance of Th1/Th2 cells.

Key words: bronchopneumonia, Xuansu cough soup, glucocorticoid, vascular intercellular adhesion molecule-1, Th1/Th2 cells

中图分类号:

R287

孙文燕, 张素雅, 杨茜. 宣肃止咳汤联合吸入型糖皮质激素治疗小儿支气管肺炎疗效及对血清VCAM-1、Th1/Th2细胞因子的影响[J]. 中华养生保健, 2024, 42(14): 22-26.

SUN Wen-yan, ZHANG Su-ya, YANG Xi. Effect of Xuansu Zhike Decoction Combined with Inhaled Glucocorticoid in the Treatment of Paediatric Bronchopneumonia and Its Effect on Serum VCAM-1 and Th1/Th2 Cytokines[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(14): 22-26.

参考文献

[1] LI Y, WANG X, BLAU D M, et al.Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis[J]. The Lancet,2022,399(10340):399.
[2] ZAR H, MOORE D P, ANDRONIKOU S, et al.Diagnosis and management of community-acquired pneumonia in children:South African Thoracic Society guidelines[J]. African Journal of Thoracic and Critical Care Medicine,2020,26(3):98.
[3] MCALLISTER D A, LIU L, SHI T, et al.Global,regional,and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis - ScienceDirect[J].The Lancet Global Health,2019,7(1):47-57.
[4] 龚海蓉,韩爱民.麻杏石甘汤加减联合布地奈德对小儿支气管肺炎临床疗效,炎性因子的影响[J].湖北中医药大学学报,2020,22(6):67-69.
[5] 胡亚美. 诸福棠实用儿科学[M].第8版.北京:人民卫生出版社,2015:1231-1287.
[6] 马融. 中医儿科学[M]. 北京:中国中医药出版社,2016.
[7] 王蕾,艾红,吴文贤.布地奈德雾化吸入治疗对支气管肺炎患儿的临床疗效及CRP,SAA水平的影响分析[J]. 检验医学与临床,2020,17(13):1915-1916.
[8] 瑞霞. 中医推拿联合复合脉冲磁性治疗仪对肺脾气虚型支气管肺炎患儿的疗效及对机体免疫功能的影响[J].山西医药杂志,2021,50(10):1633-1635.
[9] 刘昆,冀晓华,蔡建新,等.小儿清肺颗粒治疗小儿急性支气管炎痰热壅肺证的多中心、双盲、随机对照研究[J].中医杂志,2020,61(17):1530-1535+1546.
[10] 薛梦,闫美兴,张泰,等.麻黄-苦杏仁药对治疗小儿支气管肺炎网络药理学研究[J].儿科药学杂志,2022,28(5):1-6.
[11] 苑萌,卢晶,韩宝华,等.麻黄水提物对肺炎克雷伯菌所致重症肺炎幼龄大鼠细胞因子,间质纤维化以及NF-κB活化的影响[J]. 医学分子生物学杂志,2021,18(1):32-39.
[12] 晋月萍,张欣,尚楠. 黄芩片治疗肺炎呼吸衰竭模型大鼠的效果及作用机制研究[J]. 中华中医药学刊,2022,40(5):1673-7717.
[13] 赵博,段广靖,屈新亮,等.黄芩茎叶-桑白皮配伍对脂多糖致急性肺炎大鼠TRPV1信号蛋白的影响[J].中南药学,2022,20(1):14-20.
[14] LEE C M, CHANG M L, CHEN R H, et al.Thrombin - Acti - vated Platelets Protect Vascular Endothelium against Tumor Cell Extravasation by Targeting Endothelial VCAM - 1[J].Int J Mol Sci,2022,23(7):3433.
[15] 褚明慧,赵英弟,黄妍.支气管哮喘合并肺炎支原体感染患儿血清CD40L与血管细胞黏附分子-1水平的变化及意义[J].临床和实验医学杂志,2020,19(17):1814-1817.
[16] 林卓明,杨燕娜,严洪露. 哮喘合并肺炎支原体感染患儿血清VCAM-1和RBP与γ干扰素及TARC变化[J].中华医院感染学杂志,2021,31(5):787-791.
[17] 唐国英,张连花.儿童细菌性肺炎患儿血清CD40L,VCAM-1表达变化与其疾病严重程度相关关系研究[J].临床肺科杂志,2019,24(5)827-831.